In-Vitro Diagnostics (IVD) Quality Control Market Share and Forecast to 2026 - PowerPoint PPT Presentation

About This Presentation
Title:

In-Vitro Diagnostics (IVD) Quality Control Market Share and Forecast to 2026

Description:

Factors including increasing prevalence of chronic diseases, launch of new clinical laboratories, stringent mandates, as well as rising need of early diagnostics by patients drive the growth of In-Vitro Diagnostics (IVD) Quality Control market. – PowerPoint PPT presentation

Number of Views:122
Slides: 8
Provided by: Elesmith
Category: Other

less

Transcript and Presenter's Notes

Title: In-Vitro Diagnostics (IVD) Quality Control Market Share and Forecast to 2026


1
In-Vitro Diagnostics (IVD) Quality Control Market
To Reach USD 1229.3 Million By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
High prevalence of target diseases, unhealthy
lifestyle, product launches, increasing strategic
developments such as partnerships and agreements
are key factors contributing to high CAGR of
In-Vitro Diagnostics (IVD) Quality Control Market
during forecast period. Market Size USD 881.8
Million in 2018, Market Growth - CAGR of 4.3.
Market Trends Product launches and research for
In-Vitro Diagnostics (IVD) Quality Control Market.
3
Our Approach
Market Summary
  • According to the current analysis of Reports and
    Data, the global In-Vitro Diagnostics (IVD)
    Quality Control Market was valued at USD 881.8
    Million in 2018 and is expected to reach USD
    1229.3 Million by year 2026, at a CAGR of 4.3.
  • IVD quality controls are tests used to
    authenticate the consistency of IVD testing
    system to confirm precision of test findings and
    assess the influence of factors such as
    environmental conditions and operators
    performance on test results. Key recent
    developments in June 2019, Illumina, Inc.
    announced the launch of VeriSeq NIPT Solution v2,
    a CE-IVD next-generation sequencing (NGS)-based
    approach to noninvasive prenatal testing (NIPT),
    delivers the most comprehensive view of the fetal
    genome compared to other CE-IVD NIPT products.
  • Factors including increasing prevalence of
    chronic diseases, launch of new clinical
    laboratories, stringent mandates, as well as
    rising need of early diagnostics by patients
    drive the growth of In-Vitro Diagnostics (IVD)
    Quality Control market.
  • Get a Free Sample PDF Report to understand our
    report before you purchase https//www.reportsand
    data.com/sample-enquiry-form/1508

4
Our Approach
Market Summary
  • Some of the key players are Agilent Diagnostics,
    Abbott Diagnostics, Becton, Dickson and Company,
    Bio-Rad Laboratories, Inc., and ThermoFisher
    Scientific
  • Further key findings from the report suggest
  • The American Clinical Laboratory Association
    (ACLA) states that more than 7.5 billion lab
    tests are performed in U.S. annually and 80 of
    clinical decisions are taken after lab testing
  • In December 2018, BioMérieux announced its
    culture bottles BACT/ALERT BPA and BPN have
    received 510(k) clearance from the U.S. Food and
    Drug Administration (FDA) for quality control
    testing of leukocyte-reduced apheresis platelet
    (LRAP) units with the BACT/ALERT VIRTUO fully
    automated blood culture system
  • In-Vitro Diagnostics (IVD) Quality Control Market
    is fastest growing at a CAGR of 3 in Asia
    Pacific owing to rising incidence of IVD tests in
    developing countries such as India and China due
    to upsurge in number of clinical laboratories,
    global awareness among patientsContinued

5
Our Approach
Market Summary
  • Product Type (Revenue, USD Million 20162026)
  • Quality Controls
  • Whole Blood-based Controls
  • Serum-based Controls
  • Plasma-based Controls
  • Urine-based Controls
  • Other IVD Quality Controls
  • Data Management Solutions
  • Quality Assurance Services
  • Manufacturer Type (Revenue, USD Million
    20162026)
  • Instrument Manufacturer Controls
  • Independent Manufacturer Controls
  • Third-party Controls
  • Instrument Specific Manufacturer Controls

6
Our Approach
Market Summary
  • Application (Revenue, USD Million 20162026)
  • Clinical Chemistry
  • Immunochemistry
  • Haematology
  • Molecular Diagnostics
  • Coagulation/Haemostasis
  • Microbiology
  • Others
  • End User (Revenue, USD Million 20162026)
  • Hospitals
  • Clinical Laboratories
  • Home Care
  • Others
  • Order Now _at_ https//www.reportsanddata.com/checkou
    t-form/1508

7
Our Approach
About Us
  • Reports and Data is a market research and
    consulting company that provides syndicated
    research reports, customized research reports,
    and consulting services. Our solutions purely
    focus on your purpose to locate, target and
    analyze consumer behavior shifts across
    demographics, across industries and help clients
    make a smarter business decision. We offer market
    intelligence studies ensuring relevant and
    fact-based research across a multiple industries
    including Healthcare, Technology, Chemicals,
    Power, and Energy. We consistently update our
    research offerings to ensure our clients are
    aware about the latest trends existent in the
    market. Reports and Data has a strong base of
    experienced analysts from varied areas of
    expertise.
  • Contact Us
  • John Watson
  • Head of Business Development
  • Reports And Data Web www.reportsanddata.com
  • Direct Line 1-212-710-1370
  • E-mail sales_at_reportsanddata.com
Write a Comment
User Comments (0)
About PowerShow.com